The actions of exogenous dehydroepiandrosterone in experimental animals and humans

被引:0
|
作者
Svec, F
Porter, JR
机构
[1] Louisiana State Univ, Dept Med, Sch Med, Obes Res Program,Sect Endocrinol, New Orleans, LA 70112 USA
[2] Louisiana State Univ, Dept Physiol, Sch Med, Obes Res Program,Sect Endocrinol, New Orleans, LA 70112 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dehydroepiandrosterone (DHEA) is the major adrenal steroid of young adults; however, its physiologic functions, if any, are not known. The purpose of this review is to evaluate the current literature in which DHEA was administered to either humans or experimental animals to discern what these functions might be. Reports are divided into five areas: neurologic, immunologic, cardiovascular, oncologic, and metabolic. Particular attention is paid to the dosage and route of administration. This type of analysis shows that at the lowest doses, DHEA has effects on neurologic and immunologic tissues, suggesting that these two sites may be physiologic targets. DHEA also affects cardiologic and metabolic functions as well as tumor growth, but such actions require higher doses and may reflect 'pharmacologic' activities. It is proposed that DHEA's pattern of activity represents a new class of steroid hormones, the "Regnantoids." Further progress in the endocrinology of this family of steroids may only come when synthetic, long-acting analogs of DHEA are available for in vitro studies to allow correlations between hormone action and receptor binding.
引用
收藏
页码:174 / 191
页数:18
相关论文
共 50 条
  • [31] RENAL NERVES IN THE PATHOGENESIS OF HYPERTENSION IN EXPERIMENTAL-ANIMALS AND HUMANS
    KATHOLI, RE
    AMERICAN JOURNAL OF PHYSIOLOGY, 1983, 245 (01): : F1 - F14
  • [32] Quantitative differences in xenobiotic metabolism between experimental animals and humans
    Schneider, K
    Griem, P
    Hassauer, M
    Schuhmacher-Wolz, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R163 - R163
  • [33] Christian responsibility and experimental medicine; Experiments with and on humans; experiments on animals
    Grosse, HW
    ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN, 2002, 19 (04): : 195 - 202
  • [34] Pharmacokinetic modeling of hepatocyte growth factor in experimental animals and humans
    Sugiura, Tomoko
    Takahashi, Saki
    Sano, Kazusa
    Abe, Tetsushi
    Fukuta, Kazuhiro
    Adachi, Kiichi
    Nakamura, Toshikazu
    Matsumoto, Kunio
    Nakamichi, Noritaka
    Kato, Yukio
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (01) : 237 - 249
  • [35] Plasma dehydroepiandrosterone levels during experimental endotoxemia and anti-inflammatory therapy in humans
    Bornstein, SR
    Wolkersdörfer, GW
    Tauchnitz, R
    Preas, ML
    Chrousos, GP
    Suffredini, AF
    CRITICAL CARE MEDICINE, 2000, 28 (06) : 2103 - 2106
  • [36] Biomarkers of free radical damage applications in experimental animals and in humans
    De Zwart, LL
    Meerman, JHN
    Commandeur, JNM
    Vermeulen, NPE
    FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (1-2) : 202 - 226
  • [37] PHARMACOKINETICS OF ANTIBIOTICS IN NATURAL AND EXPERIMENTAL SUPERFICIAL COMPARTMENTS IN ANIMALS AND HUMANS
    RYAN, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 : 1 - 16
  • [38] THE FUNCTIONAL PATHOLOGY OF FROSTBITE AND THE PREVENTION OF GANGRENE IN EXPERIMENTAL ANIMALS AND HUMANS
    LANGE, K
    BOYD, LJ
    SCIENCE, 1945, 102 (2641) : 151 - 152
  • [39] Broad Spectrum of Hepatocyte Inclusions in Humans, Animals, and Experimental Models
    Strnad, Pavel
    Nuraldeen, Renwar
    Guldiken, Nurdan
    Hartmann, Daniel
    Mahajan, Vineet
    Denk, Helmut
    Haybaeck, Johannes
    COMPREHENSIVE PHYSIOLOGY, 2013, 3 (04) : 1393 - 1436